Study to evaluate the effect of nasal drops in sleeplessness after menopause
Not Applicable
- Conditions
- Health Condition 1: G470- Insomnia
- Registration Number
- CTRI/2024/07/071299
- Lead Sponsor
- Dr Kavya S
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Women subjects aged 40-60 years post-menopausal.
2.Diagnosed cases of Anidra (deranged quality/quantity of sleep) /Primary Insomnia taken.
3.Subjects meeting the diagnostic criteria.
Exclusion Criteria
1.Subjects already receiving regular sleep therapy (sleeping pills or tranquilizers), diagnosed with severe mental illness, or experiencing chronic physical pain.
2.Subjects with systemic disorders, neurological disorders, dementia.
3.Subjects with Antipsychotic treatment.
4.Subjects with other systemic involvements which interfere in carrying out research will be excluded.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Marked improvement in quality of sleep, in post menopausal induvial assessed on PSQI questionnaire based out come.Timepoint: Pre-Study Assessment - 0th Day <br/ ><br>(1st Assessment) <br/ ><br>2nd Assessment - 15th Day <br/ ><br>1st Follow up - 30th Day. <br/ ><br>2nd Follow up - 45th Day.
- Secondary Outcome Measures
Name Time Method Generation of thorough and detailed data analysis across various dimensions of the disease. <br/ ><br>Improvement in quality of life will be expected. <br/ ><br>Recording of any potential unexpected adverse effects. <br/ ><br>Timepoint: Pre-Study Assessment - 0th Day <br/ ><br>(1st Assessment) <br/ ><br>2nd Assessment - 15th Day <br/ ><br>1st Follow up - 30th Day. <br/ ><br>2nd Follow up - 45th Day.